⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Illumen Therapeutics
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Illumen Therapeutics just got measured.
5/10 means Illumen Therapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About Illumen Therapeutics
Illumen Therapeutics is pioneering the development of first-in-class PARN inhibitor drugs that boost functional p53, the 'Guardian of the Genome,' to treat aggressive cancers and improve survival.
Key Topics
Details
Industry: Food & Beverage
illumentx.comAI Visibility Breakdown
2
Structured Data
5
Content Structure
5
Entity Clarity
3
E-E-A-T Signals
7
Technical AEO
7
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Your Ingredient Label Has a Story. Is Anyone Telling It?
Food is the most intimate purchase a person makes. You're deciding what goes into your body, what you feed your family, what aligns with your values. That decision deserves more than a label and a hope.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Illumen Therapeutics.
Source & Attribution
Scored by Engagemii on July 2, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/illumentx
Cite this score: Engagemii (2026). "AEO Score for Illumen Therapeutics." Retrieved from https://engagemii.com/aeo/brands/illumentx
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform